Literature DB >> 24880668

Hypercholesterolemia increases plasma saturated and n-6 fatty acids altering prostaglandin homeostasis and promotes endothelial dysfunction in rabbits.

M Medina1, M R Alberto, L Sierra, C Van Nieuwenhove, S Saad, M I Isla, S Jerez.   

Abstract

The present study evaluated the plasma fatty acid levels and the vascular prostaglandin (PG) release in a rabbit model of early hypercholesterolemia with endothelial dysfunction. Rabbits were fed either a control diet (CD) or a diet containing 1 % cholesterol (HD) for 5-6 weeks. The level of fatty acids was measured in plasma. The levels of PG and nitric oxide (NO) released from the aorta were also determined. Vascular morphology of the aorta was characterized by intima and media thickness measurements. The rabbits fed with HD had higher levels of arachidonic acid (ARA) and lower levels of oleic acid. The linoleic acid level was unchanged. PGI(2) and NO were diminished and PGF(2α) levels, the PGI(2)/TXA(2) ratio and the intima/media ratio were increased in rabbits fed with HD. In conclusion, feeding HD for a short period increased ARA plasma levels and unbalanced release of vasodilator/vasoconstrictor PG redirected the pathway to vasoconstrictor metabolite release. These lipid metabolism alterations in addition to the reduced NO levels and the moderate changes in the vascular morphology contributed to the endothelial dysfunction in this animal model. Therefore, the present findings support the importance of early correction or prevention of high cholesterol levels to disrupt the endothelial dysfunction process that leads to cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24880668     DOI: 10.1007/s11745-014-3915-6

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  39 in total

1.  DYNAMIC ASPECTS OF CHOLESTEROL ESTER METABOLISM IN RABBITS WITH ATHEROSCLEROSIS.

Authors:  L Swell; M D Law; C R Treadwell
Journal:  J Nutr       Date:  1963-11       Impact factor: 4.798

2.  Nitric oxide (NO) inhibits prostaglandin E2 9-ketoreductase (9-KPR) activity in human fetal membranes.

Authors:  M G Farina; S Billi; M S Sordelli; M L Ribeiro; G Di Girolamo; E Lombardi; A M Franchi
Journal:  Prostaglandins Other Lipid Mediat       Date:  2006-04-17       Impact factor: 3.072

3.  Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis.

Authors:  D S Celermajer; K E Sorensen; V M Gooch; D J Spiegelhalter; O I Miller; I D Sullivan; J K Lloyd; J E Deanfield
Journal:  Lancet       Date:  1992-11-07       Impact factor: 79.321

4.  Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation.

Authors:  G A FitzGerald; B Smith; A K Pedersen; A R Brash
Journal:  N Engl J Med       Date:  1984-04-26       Impact factor: 91.245

5.  Concentrations of prostaglandin endoperoxide synthase and prostaglandin I2 synthase in the endothelium and smooth muscle of bovine aorta.

Authors:  D L DeWitt; J S Day; W K Sonnenburg; W L Smith
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

Review 6.  Prostanoid function and cardiovascular disease.

Authors:  Miguel A Iñiguez; Cristina Cacheiro-Llaguno; Natalia Cuesta; Manuel D Díaz-Muñoz; Manuel Fresno
Journal:  Arch Physiol Biochem       Date:  2008-07       Impact factor: 4.076

7.  Increased prostacyclin and thromboxane A2 biosynthesis in atherosclerosis.

Authors:  J L Mehta; D Lawson; P Mehta; T Saldeen
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

8.  Simultaneous quantification of seven prostanoids using liquid chromatography/tandem mass spectrometry: the effects of arachidonic acid on prostanoid production in mouse bone marrow-derived mast cells.

Authors:  Takanori Hishinuma; Kaori Suzuki; Masayoshi Saito; Hiroaki Yamaguchi; Naoto Suzuki; Yoshihisa Tomioka; Izumi Kaneko; Masao Ono; Junichi Goto
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2007-06-21       Impact factor: 4.006

9.  Phosphatidylinositol (PI) and PI-associated arachidonate are elevated in platelet total membranes of type IIa hypercholesterolemic subjects.

Authors:  C Mosconi; S Colli; E Tremoli; C Galli
Journal:  Atherosclerosis       Date:  1988-08       Impact factor: 5.162

10.  Endothelial dysfunction and improvement of the angiotensin II-reactivity in hypercholesterolemic rabbits: role of cyclooxygenase metabolites.

Authors:  Susana Jerez; Liliana Sierra; Alfredo Coviello; Maria Peral de Bruno
Journal:  Eur J Pharmacol       Date:  2007-10-25       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.